Le Lézard
Classified in: Health, Science and technology
Subject: Merger/Acquisition

Cellix Bio Pharma Completes the Acquisition of Avaca Pharma

Cellix Bio Pharma completes the acquisition of Avaca Pharma, a formulation development company. Avaca Pharma services include discovery, formulation development, regulatory support, and product development activities.

The acquisition of Avaca Pharma provides Cellix Bio Pharma with world-class expertise in NME/NCE discovery R&D services and a unique and extensive set of high-content and complex formulations. Combined with Cellix Bio's established small molecule discovery and drug development capabilities, this expansion uniquely positions Cellix Bio Pharma as a leading provider of integrated R&D services across large and small molecule platforms a base for further expansion.

With a vision of an innovative approach of execution, exceptional customer service, and focus on providing value, Cellix Bio Pharma is delighted to offer expanded leading-edge service solutions.

Avaca Pharma Research and Development Centre (RDC) at IDA Pashamylaram, Hyderabad, has a total high-quality, compliant space of 6000 sq. ft. in a 1.2-acre location, of which Formulation R&D occupies 3000 sq. ft. and Analytical Operations, 3000 sq. ft., with provisions for expansion.

Avaca Pharma Commercial Operations Centre (COC) is located between Hyderabad and Vijayawada, Andhra Pradesh. The new planned construction will host commercial manufacturing, packaging, analytical, and warehousing facilities within the 14 acres environmentally friendly campus. The facility will have a total built-up cGMP space of 126,685 sq.ft. meeting regulatory compliance standards.

About Cellix Bio Pharma

Cellix Bio Pharma is a wholly-owned subsidiary of Cellix Bio. Cellix Bio Pharma focuses on the development of pharmaceutical formulations. Our long experience in developing pharmaceutical products enables us to find the most cost-effective and safest way to clinical testing of your product. We are in Hyderabad, in one of the top science hubs in India. The team members have been working with drug discovery, development, drug delivery technologies in different surroundings. They have strong product development and regulatory filings pipeline in oral, parenteral, inhalation, ocular, and topical products at various stages. More information on Cellix Bio Pharma: www.cellixbiopharma.com

About Avaca Pharma

Avaca Pharma is a new-gen pharmaceutical development and commercialization organization with a vision to innovate for better health. Rooted in integrity, technical acumen, customer service, and reliability. Our organizational goal is to thrive for the best patient outcome. Avaca Pharma is vested in bringing quality pharmaceutical products with a patient-centric approach. More information on Avaca Pharma: www.avacapharma.com

About Cellix Bio

Cellix Bio is an innovative biopharmaceutical company focused on developing innovative technologies that have the potential to make a significant medical and commercial impact with value-driven clinical outcomes. Cellix Bio works closely with the scientific community, universities, and research institutions to advance and build the value of Synergix AITM technology, develop the most promising intellectual property, and create value for its stakeholders and investors. Cellix Bio has a robust pipeline of new medicines addressing unmet medical needs across diverse therapeutic areas, including neurology, ophthalmic, dermatology, oncology, inflammation, and metabolic diseases. More information on Cellix Bio: www.cellixbio.com

These press releases may also interest you

at 03:20
The healthcare sector is a key focus of Orange's 2025 strategic plan. As part of this, Orange Business Services is reorganizing its healthcare entities, Enovacom and Orange Healthcare, to fully meet the needs of the players in this sector, which is...

at 03:05
COVID-19 market impact analysis anticipates Negative and Inferior growth for the automotive central gateway module market, while the 44% of the market's growth will originate from APAC during the forecast period, according to Technavio report Global...

at 03:05
WISE Srl, a medical device company developing next-generation implantable leads for neuromonitoring, neuromodulation and brain-machine interfacing, today announced the closing of a EUR 15 million Series C financing round. New investors, led by CDP...

at 03:05
SDL (LSE: SDL), the intelligent language and content company, announces a partnership with Congree Language Technologies GmbH, experts in authoring assistance tools and content optimization, to provide linguistic guidance, terminology checks and...

at 03:05
Enesi Pharma ("Enesi"), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, is delighted to announce that ImplaVax® has...

at 03:00
castLabs, secure digital video delivery solutions provider, ContentArmor the bitstream watermarking vendor and BitCine Technologies (dba CineSend), a leading provider of cloud-based media asset management tools for the film and television industry,...

News published on 4 august 2020 at 18:35 and distributed by: